Resolved

TRI-JORDYNA 21

GLENMARK PHARMACEUTICALS CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TRI-JORDYNA 21 in Canada?

Not currently. The most recent shortage report for TRI-JORDYNA 21 0.25MG 0.18MG 0.215MG 0.035MG 0.035MG 0.035MG is marked resolved (last updated June 24, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength0.25MG 0.18MG 0.215MG 0.035MG 0.035MG 0.035MG

Last updated2026-06-24

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02486296

Strength

0.25MG 0.18MG 0.215MG 0.035MG 0.035MG 0.035MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

NORGESTIMATE ETHINYL ESTRADIOL

Tier

Unrated

Last Updated

2026-06-24

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from GLENMARK PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS

DIN 02466783

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

DIN 02462060

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21

DIN 02421437

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28

DIN 02421445

GLN-APREMILAST

30MG · DIN 02518910

GLN-ATOVAQUONE

750MG · DIN 02528495